1. Home
  2. SRI vs HUMA Comparison

SRI vs HUMA Comparison

Compare SRI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.57

Market Cap

161.7M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.16

Market Cap

229.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
HUMA
Founded
1965
2004
Country
United States
United States
Employees
N/A
220
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
229.7M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
SRI
HUMA
Price
$5.57
$1.16
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$16.00
$9.29
AVG Volume (30 Days)
182.2K
3.6M
Earning Date
06-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
$7.42
N/A
Revenue Next Year
N/A
$731.05
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$3.54
$0.88
52 Week High
$9.71
$3.35

Technical Indicators

Market Signals
Indicator
SRI
HUMA
Relative Strength Index (RSI) 26.58 52.23
Support Level $5.58 $1.09
Resistance Level $6.35 $1.27
Average True Range (ATR) 0.42 0.08
MACD -0.31 -0.00
Stochastic Oscillator 4.76 38.16

Price Performance

Historical Comparison
SRI
HUMA

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: